Terms ending in 2030
Every in-force patent on Hemanext Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,284,616 | Irradiation of Red Blood Cells and Anaerobic Storage In force · Medium confidence | Hemanext Inc. | In force | Medium confidence | |
| US 11,433,164 | System for Extended Storage of Red Blood Cells and Methods of Use In force · Medium confidence | Hemanext Inc. | In force | Medium confidence | |
| US 12,089,589 | Irradiation of Red Blood Cells and Anaerobic Storage In force · Medium confidence | Hemanext Inc. | In force | Medium confidence | |
| US 12,502,462 | System for Extended Storage of Red Blood Cells and Methods of Use In force · Medium confidence | Hemanext Inc. | In force | Medium confidence | |
| US 9,844,615 | System for Extended Storage of Red Blood Cells and Methods of Use In force · Medium confidence | Hemanext Inc. | In force | Medium confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.